Vous pouvez maintenant accéder à la version de decembre 2024 du Répertoire canadien des médicaments à partir de Terminology Gateway et du serveur terminologique, à des fins de consultation ou d’implantation.
En savoir plus >
We would like to extend our thanks to all those who have completed a review of and submitted comments on the Interoperability Specifications PS-CA v0.2 and CA:FeX v0.1. The open review period is now closed.
In preparation for PS-CA v0.3 and CA:FeX v0.2, we will be dispositioning the comments, incorporating those identified for inclusion in the next version and developing the release notes. For comments which cannot be included within the next release, a timeline and approach will be communicated. If common themes arise, webinar(s) will be scheduled to address the themes.
For release schedule details, please visit the following:
We would like to extend our thanks to all those who have completed a review of and submitted comments on the PS-CA v0.2 and/or the CA:FeX v0.1. If you have not yet had an opportunity to submit your comments, please note that the open review period for both specifications closes on Monday, February 14th.
Please visit the corresponding release pages for access to the specifications and details on how to provide feedback.
We are pleased to announce that the Public Review period for two interoperability specifications are now open.
All Collaborators are invited to review and submit comments on the specifications. Please visit the corresponding release pages for access to the specifications and details on how to provide feedback.
We kindly ask that each organization submit all comments within one spreadsheet submission per specification.
The timeline for Public Review is: January 28 – February 14, 2022.
If you have general comments or questions about Interoperability or on the specifications, please feel free to post in this thread. We will have our subject matter experts available to answer. This is also a great way to spark conversations with other stakeholders about how they are addressing particular topics.